166 related articles for article (PubMed ID: 26207917)
41. SP1-induced lncRNA ZFPM2 antisense RNA 1 (ZFPM2-AS1) aggravates glioma progression via the miR-515-5p/Superoxide dismutase 2 (SOD2) axis.
Zhang Y; Zhang Y; Wang S; Li Q; Cao B; Huang B; Wang T; Guo R; Liu N
Bioengineered; 2021 Dec; 12(1):2299-2310. PubMed ID: 34077295
[TBL] [Abstract][Full Text] [Related]
42. Association of Single Nucleotide Polymorphisms (SNPs) in Genes Encoding for Folate Metabolising Enzymes with Glioma and Meningioma in Indian Population.
Kumawat R; Gowda SH; Debnath E; Rashid S; Niwas R; Gupta Y; Upadaya AD; Suri A; Chandra PS; Gupta DK; Lakshmy R; Sarkar C; Sinha S; Chosdol K
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3415-3425. PubMed ID: 30583664
[TBL] [Abstract][Full Text] [Related]
43. Fine-mapping of a region of chromosome 5p15.33 (TERT-CLPTM1L) suggests a novel locus in TERT and a CLPTM1L haplotype are associated with glioma susceptibility in a Chinese population.
Zhao Y; Chen G; Zhao Y; Song X; Chen H; Mao Y; Lu D
Int J Cancer; 2012 Oct; 131(7):1569-76. PubMed ID: 22213090
[TBL] [Abstract][Full Text] [Related]
44. ERCC2 rs13181 polymorphism association with glioma susceptibility in a Chinese population.
Gao X; Tang YJ; Zhang GF; Yu L; Qi ST
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323065
[TBL] [Abstract][Full Text] [Related]
45. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
[TBL] [Abstract][Full Text] [Related]
46. Genetic effects of XRCC4 and ligase IV genes on human glioma.
Jiao K; Qin J; Zhao Y; Zhang H
Neuroreport; 2016 Sep; 27(14):1024-30. PubMed ID: 27508978
[TBL] [Abstract][Full Text] [Related]
47. Lysyl oxidase genetic variants and the prognosis of glioma.
Han S; Feng S; Yuan G; Dong T; Gao D; Liang G; Wei X
APMIS; 2014 Mar; 122(3):200-5. PubMed ID: 23758270
[TBL] [Abstract][Full Text] [Related]
48. Genetic polymorphisms in the DNA repair gene XRCC1 and susceptibility to glioma in a Han population in northeastern China: a case-control study.
Wang D; Hu Y; Gong H; Li J; Ren Y; Li G; Liu A
Gene; 2012 Nov; 509(2):223-7. PubMed ID: 22951806
[TBL] [Abstract][Full Text] [Related]
49. Correlations of MGMT genetic polymorphisms with temozolomide resistance and prognosis of patients with malignant gliomas: a population-based study in China.
Wang HW; Xu ZK; Song Y; Liu YG
Cancer Gene Ther; 2017 May; 24(5):215-220. PubMed ID: 28409559
[TBL] [Abstract][Full Text] [Related]
50. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
[TBL] [Abstract][Full Text] [Related]
51. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
Fults D; Pedone C
Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623
[TBL] [Abstract][Full Text] [Related]
52. Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.
da Silveira Fd; Lopes Bde A; da Fonseca CO; Quirico-Santos T; de Palmer Paixão IC; de Amorim LM
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1347-54. PubMed ID: 22481252
[TBL] [Abstract][Full Text] [Related]
53. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
54. Angiotensin-converting enzyme insertion/deletion gene polymorphisms and the risk of glioma in an Algerian population.
Benenemissi IH; Sifi K; Sahli LK; Semmam O; Abadi N; Satta D
Pan Afr Med J; 2019; 32():197. PubMed ID: 31312309
[TBL] [Abstract][Full Text] [Related]
55. Fine mapping analysis of a region of 20q13.33 identified five independent susceptibility loci for glioma in a Chinese Han population.
Song X; Zhou K; Zhao Y; Huai C; Zhao Y; Yu H; Chen Y; Chen G; Chen H; Fan W; Mao Y; Lu D
Carcinogenesis; 2012 May; 33(5):1065-71. PubMed ID: 22387365
[TBL] [Abstract][Full Text] [Related]
56. DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression.
Zheng S; Houseman EA; Morrison Z; Wrensch MR; Patoka JS; Ramos C; Haas-Kogan DA; McBride S; Marsit CJ; Christensen BC; Nelson HH; Stokoe D; Wiemels JL; Chang SM; Prados MD; Tihan T; Vandenberg SR; Kelsey KT; Berger MS; Wiencke JK
Neuro Oncol; 2011 Mar; 13(3):280-9. PubMed ID: 21339190
[TBL] [Abstract][Full Text] [Related]
57. Association between the XRCC1 Arg194Trp polymorphism and glioma risk: an updated meta-analysis.
Xu C; Chen P; Liu W; Gu AH; Wang XR
Asian Pac J Cancer Prev; 2014; 15(17):7419-24. PubMed ID: 25227852
[TBL] [Abstract][Full Text] [Related]
58. Single Nucleotide Polymorphisms in IL-10, IL-12p40, and IL-13 Genes and Susceptibility to Glioma.
Shamran HA; Ghazi HF; Al-Salman A; Al-Juboory AA; Taub DD; Price RL; Nagarkatti M; Nagarkatti PS; Singh UP
Int J Med Sci; 2015; 12(10):790-6. PubMed ID: 26516307
[TBL] [Abstract][Full Text] [Related]
59. Deregulated expression of the clock genes in gliomas.
Chen Z; Liu P; Li C; Luo Y; Chen I; Liang W; Chen X; Feng Y; Xia H; Wang F
Technol Cancer Res Treat; 2013 Feb; 12(1):91-7. PubMed ID: 22905804
[TBL] [Abstract][Full Text] [Related]
60. No association between EGF +61 A/G polymorphism and increased risk of glioma.
Liu X; Li L; Chen X; Wang X; Mu L; Li Y; Xu Q; Xie Q; Lu F
Int J Biol Markers; 2009; 24(2):77-82. PubMed ID: 19634110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
